Generation of an induced pluripotent stem cell line (IUFi002-A) from a Leigh syndrome patient carrying mutations in the NDUFS1 gene

Stem Cell Res. 2022 Dec:65:102971. doi: 10.1016/j.scr.2022.102971. Epub 2022 Nov 14.

Abstract

Human dermal fibroblasts from a Leigh Syndrome (LS) patient harboring the heterozygous NDUFS1 R557X/D618N compound mutation were reprogrammed to generate integration-free induced pluripotent stem cells (iPSCs). The full characterization of IUFi002-A-iPSCs demonstrated that the line is free of exogenous reprogramming genes and maintains the genomic integrity. IUFi002-A-iPSCs' pluripotency was confirmed by the expression of pluripotency markers and embryoid body-based differentiation into cell types representative of each of the three germ layers. The generated iPSC line provides a powerful tool to investigate LS and analyze the molecular mechanisms underlying NDUFS1 mutations-induced pathology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Genomics
  • Humans
  • Induced Pluripotent Stem Cells* / enzymology
  • Induced Pluripotent Stem Cells* / pathology
  • Leigh Disease* / genetics
  • Leigh Disease* / pathology
  • Mutation
  • NADH Dehydrogenase* / genetics

Substances

  • NADH Dehydrogenase
  • NDUFS1 protein, human